<DOC>
	<DOCNO>NCT01068912</DOCNO>
	<brief_summary>This Phase 2 , randomize , double-blind , placebo-controlled multicenter study evaluate efficacy safety two dos favipiravir adult patient uncomplicated influenza .</brief_summary>
	<brief_title>Dose-Finding Study Favipiravir Treatment Uncomplicated Influenza</brief_title>
	<detailed_description>This Phase 2 , randomize , double-blind , placebo-controlled , multicenter study design evaluate efficacy safety 5-day regimen favipiravir influenza patient age 20-80 year . Enrolled patient randomly assign 1 3 parallel treatment dose group : Placebo ; Low-dose favipiravir ( 1000 mg favipiravir BID 1 day , follow 400 mg favipiravir BID 4 day ) ; High-dose favipiravir ( 1200 mg favipiravir BID 1 day , follow 800 mg favipiravir BID 4 day ) .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . Patients test positive influenza A B commercially available Rapid Antigen Test ( RAT ) nasopharynx . A patient negative RAT result may still enroll sponsor investigator agree know influenza outbreak circulate community . 2 . Patients ≥ 20 &lt; 65 year age temperature ( oral ) 100.4°F ( 38.0°C ) ; patient ≥ 65 year age temperature ( oral ) 100.0°F ( 37.8°C ) first visit , 6 hour prior antipyretic take . 3 . Patients 2 follow symptom ( moderate severe intensity ) time enrollment : Cough Sore throat Headache Nasal congestion Feeling feverish Body ache pain Fatigue ( tiredness ) 1 . Patients influenza symptom fever ( i.e. , one symptom list inclusion criterion ) 36 hour prior study screen . 2 . Patients underlie chronic respiratory disease ( e.g. , chronic obstructive pulmonary disease [ COPD ] , chronic bronchitis , diffuse panbronchiolitis , bronchiectasis , pulmonary emphysema , pulmonary fibrosis , bronchial asthma , old tuberculosis ) . 3 . Patients begin study suspect bacterial respiratory infection ( i.e. , expectoration purulent mucopurulent sputum and/or infiltrate lung chest xray , etc. ) . 4 . Patients serious chronic disease . For example , patient HIV , cancer ( i.e. , require chemotherapy within precede 6 month ) , cirrhosis ( endstage ) , and/or unstable renal , cardiac , pulmonary , neurologic , vascular , endocrinologic disease state require medication dose adjustment within last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Influenza</keyword>
</DOC>